Watchlist Price Alert

Neoleukin Therapeutics In... (NLTX)

NASDAQ: NLTX · Real-Time Price · USD

3.49

0.05 (1.45%)

At close: Dec 18, 2023, 9:00 PM

Neoleukin Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-57.56M	-60.69M	-33.28M	-69.44M	-31.59M	-50.18M	-37M
Depreciation & Amortization	2.61M	2.28M	1.82M	340K	n/a	n/a	n/a
Stock-Based Compensation	8.83M	11.56M	5.62M	7.68M	4.7M	3.84M	1.97M
Other Working Capital	-1.37M	-558K	-2.05M	290K	1.04M	-905K	-109K
Other Non-Cash Items	-376K	n/a	293K	47.72M	741K	709K	104K
Deferred Income Tax	n/a	n/a	n/a	263K	n/a	n/a	n/a
Change in Working Capital	885K	-700K	966K	-1.95M	-5.43M	917K	4.71M
Operating Cash Flow	-45.61M	-47.56M	-24.57M	-15.39M	-31.58M	-44.72M	-30.23M
Capital Expenditures	-1.11M	-3.26M	-2.22M	-879K	-49K	-494K	-713K
Cash Acquisitions	n/a	n/a	n/a	191K	n/a	n/a	n/a
Purchase of Investments	-107.52M	n/a	n/a	n/a	n/a	-6M	-106.44M
Sales Maturities Of Investments	49.5M	n/a	n/a	n/a	56M	70.5M	59.1M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-59.13M	-3.26M	-2.22M	-688K	55.95M	64.01M	-48.06M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	82K	372K	199K	560K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	161K	732K	77.14M	82.24M	570K	423K	71.11M
Financial Cash Flow	161K	732K	77.14M	82.24M	570K	423K	71.11M
Net Cash Flow	-104.58M	-50.09M	50.34M	66.17M	24.9M	19.73M	-7.22M
Free Cash Flow	-46.72M	-50.82M	-26.79M	-16.27M	-31.63M	-45.21M	-30.94M